JFGIW
TXMD icon

Johnson Financial Group Inc (Wisconsin)’s TherapeuticsMD TXMD Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3 Buy
+1
New +$2 ﹤0.01% 885

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s TXMD Position: Q1 2026 in Review

Johnson Financial Group Inc (Wisconsin) opened a new position in TherapeuticsMD (TXMD) in Q1 2026: 1 share worth $3. The stake represents ﹤0.01% of the portfolio and ranks #885 among its holdings.

49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.

  • Johnson Financial Group Inc (Wisconsin) held 1 share of TherapeuticsMD worth $3 as of Q1 2026.
  • TherapeuticsMD was a new Johnson Financial Group Inc (Wisconsin) position in Q1 2026.
  • TherapeuticsMD made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q1 2026, its #885 holding.
  • 49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2026, filed 7 May 2026.